
Memory & Thinking Improve in Crenezumab Dementia Trial
An Alzheimer’s vaccination called crenezumab just finished 2 trials. The drug showed clear, positive cognitive improvements in people with mild Alzheimer’s. Learn more about the

An Alzheimer’s vaccination called crenezumab just finished 2 trials. The drug showed clear, positive cognitive improvements in people with mild Alzheimer’s. Learn more about the

PseudoBulbar Affect (PBA) is a distressing neurologic condition characterized by sudden and uncontrolled outbursts of laughing and/or crying. Learn how Nuedexta, a new drug in

VIDEO & ARTICLE: Why were people with rheumatoid arthritis getting less Alzheimer’s? Find out how the answer to this question has triggered an anti-Alzheimer’s trial

RESEARCH VIDEO – Alzheimer’s International Conference: See NIH-sponsored research exploring intranasal insulin as a potentially strong treatment for dementia.

The Alzheimer’s drugs on the market today help compensate for the problems caused by Alzheimer’s. However, they do not stop the disease or change its

VIDEO The A4 Study uses the drug solanezumab in one of the most ambitious attempts yet to thwart Alzheimer’s. The major clinical trial got underway

Research has shown that the Parkinson’s drug, rasagiline, could be a viable therapeutic option for people with Alzheimer’s disease. Learn about the new effort to

VIDEO + ARTICLE CERE-110 is a big step forward for Alzheimer’s clinical trials. It induces brain cells to make their own nerve-growth-factor, so they can

VIDEO & ARTICLE: See how doctors implant a deep-brain-stimulation device in “The Advance Study”. Learn how its electrodes stimulate a part of the brain called

VIDEO+ARTICLE Cognoptix announced strong results in a clinical trial of its SAPPHIRE II eye test. It successfully identified Alzheimer’s via the human eye’s beta-amyloid signature.

DEMENTIA GIFT IDEAS: People with Alzheimer’s may lose abilities, but feelings still matter. What once wasn’t much of a gift, may now be a great one. What were nice presents may no longer be right. See these thoughtful suggestions.

Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more older adults could qualify for treatment than current use reflects. As diagnosis becomes easier, demand for drugs like Leqembi could shift sharply.

Israel pairs the developed world’s highest birth rate with the lowest crude dementia prevalence in a major European comparison—an advantage rooted in demographics that gives the country valuable time to prepare better for caregivers and families.

Fresh air and exercise, improved appetite, fewer medications and happier family visits typify the world’s first “Dementia Village”. See how an inspired nursing home manager took a dreary hospital and turned it into a respect-filled, compassionate community.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
No spam, only news and updates.